Jan 15,2022

How (and Why) to Use Health Tracking Tools During Cancer Care

Jasper Health shares how to use its tool for cancer care, including symptom and side effect tracking, medications, mood, nutrition, sleep, physical activity, and so forth.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 17,2022

OncoHost Announces Interim Results From PROPHETIC Trial, Multicenter Assessment Of NSCLC Patient Response To Immunotherapy

OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, announced results from its ongoing multicenter clinical trial, PROPHETIC. These interim results confirm that through proteomic analysis of just one blood test before treatment, OncoHost’s AI platform, PROphet®, can predict response to cancer treatment for non-small cell lung cancer (NSCLC) patients with remarkably high accuracy at three months, six months and one year.

CLINICAL STUDY

#ai/software

#platform

View Analyst & Ambassador Comments
Go to original news
Jan 28,2022

2022 Predictions for AI and Machine Learning in Healthcare

Dr. Ofer Sharon, CEO of OncoHost and other players in the oncology therapeutics market shared their vision on AI and Machine Learning applications in 2022.

View Analyst & Ambassador Comments
Go to original news
Feb 04,2022

Indian Express Podcast – Crucial role of technology in cancer care

Digital technology has a crucial role in oncology and healthcare as, in recent times it has become a necessary evil to bridge the gaps in cancer care.To know more, listen in to this podcast, titled Cancer Care Matters as R. Venkataramanan, Founder, Karkinos Healthcare and Girish Raghavan, VP GE Healthcare, Edison Platform, talk about the role of digital technologies and AI in Cancer Care.

#ai/software

View Analyst & Ambassador Comments
Go to original news
Feb 04,2022

Technology to improve cancer care outcomes in India

Dr. Moni Kuriakose & R. Venkataramanan from Karkinos Healthcare explains how to improve cancer care by closing the gaps between primary care and cancer care facilities with the help fo the technology. Cancer treatment requires multidisciplinary care delivery as per a predefined protocol, right from diagnosis to treatment and surveillance. Enabled by the Karkinos cancer technology platform, six community cancer centers in multispecialty hospitals are connected to two apex cancer centers and an advanced cancer diagnostic center in the city. This network is being expanded to cover the entire state, with 70 community cancer centers proposed state-wide. This potential blueprint can be replicated in any other state or country.

PRODUCT

#telehealth

#platform

View Analyst & Ambassador Comments
Go to original news
Nov 18,2022

Impact of Covid-19 on Cancer Care – Where Karkinos Healthcare makes a difference

Karkinos Healthcare is addressing several problems associated with delivering ubiquitous cancer care by leveraging its digital oncology service delivery platform. The company’s proprietary distributed cancer care network envisages the use of digital technology and resource distribution to provide highest quality care closest to the patient’s home.

PRODUCT

#platform

#telehealth

View Analyst & Ambassador Comments
Go to original news
Feb 09,2022

Imagia Cybernetics & Canexia Health Merge to Supercharge Precision Oncology Accessibility

Imagia Cybernetics, an AI-healthcare company that accelerates oncology solutions generated from real world data, today announced its merger with Canexia Health. Canexia is an oncology innovator that streamlines complex cancer genomic information which allows oncologists to identify optimal treatment selection and patient monitoring. The transaction is expected to close at the end of February, subject to shareholder approval.

COLLABORATION MERGERS & ACQUISITION

#data & technology

#ai/software

View Analyst & Ambassador Comments
Go to original news
Feb 09,2022

Oncology patients’ communication experiences during COVID-19: comparing telehealth consultations to in-person visits

The COVID-19 pandemic created significant disruptions in cancer care, much of which was transitioned to telehealth. Because telehealth alters the way clinicians and patients interact with one another, this investigation examined patients’ perceptions of their communication with clinicians during the pandemic. In addition to demographic and health-related information, respondents completed measures of patient-centered communication and evaluated how their communication in telehealth sessions compared with in-person visits.

CLINICAL STUDY

#telehealth

View Analyst & Ambassador Comments
Go to original news
Feb 01,2022

Jasper Health Raises $25 Million in Series A Funding to Increase Access to Comprehensive Cancer Experience and Care Navigation Platform

Jasper Health, a first-of-its-kind cancer care navigation and experience platform, today announced a $25 million Series A funding round led by General Catalyst. The round, which was joined by new and existing investors Human Capital, W Health Ventures, Redesign Health, and 7wireVentures, brings Jasper Health’s total funding to approximately $31 million.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 04,2022

Astellas Initiates Charitable Donations to Support Four Organizations Focused on Improving Access to Quality Cancer Care and Additional Areas of Urgent Need

Astellas Pharma Inc. (“Astellas”) today announced its expanding commitment to improving access to health by providing donations to four charitable organizations serving patients in need in countries where Astellas has a presence. The newly initiated support includes two donations in cancer care and the others focused on eye care and neglected tropical diseases (NTDs).

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY